Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Is Childhood Vaccination Disrupted by Excessive Use of Antibiotics?
Editorial Is Childhood Vaccination Disrupted by Excessive Use of Antibiotics?

Nothing could make the benefits of vaccination easier to understand than the recent COVID-19 pandemic and its catastrophic effects. However, when it comes to vaccinating children and teenagers, many people around the world showed reluctance due to the potential negative effects. Although the

3 Reasons Why Cloud Contact Centres Are the Next Step in Customer Success
Editorial 3 Reasons Why Cloud Contact Centres Are the Next Step in Customer Success

At the same time that the implications of the global pandemic have created difficulties for many, they have also sparked an opportunity for growth and change.  One key area that has continued to evolve even as we return to a sense of normality, is customer experience. Indeed, according to Deloitte,

Developing COVID-19 Vaccines and Treatments for Children
Editorial Developing COVID-19 Vaccines and Treatments for Children

More than two years have now passed since the beginning of the COVID-19 pandemic—an epidemic that turned into the most serious healthcare crisis in modern history. According to Johns Hopkins University, 6.16 million people have lost their lives to the disease, and more than 493 million have been i

Do COVID-19 boosters increase immune response?
Editorial Do COVID-19 boosters increase immune response?

As the COVID-19 pandemic continues to spread across the globe, many people are worried that the current vaccination may not be sufficient to curb the spread of the virus. While the successful development of effective vaccines has been one of the greatest weapons against the pandemic, Delta and

Is the New Merck Pill a Valuable Weapon Against the COVID-19 Pandemic?
Editorial Is the New Merck Pill a Valuable Weapon Against the COVID-19 Pandemic?

The COVID-19 pandemic has reshaped industries—especially healthcare and biopharma.  While vaccines provided governments and people in the US and abroad with a new way of fighting the virus, more help is needed. As a significant percentage of the population remains unvaccinated, and new strains of th

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later